Polymyositis

Overview of inflammatory myopathy.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
RheumatologyNeurology

Clinical Guidelines

British Society for Rheumatology guideline on management of adult and juvenile idiopathic inflammatory myopathies
National
Clinical Commissioning Policy: Rituximab for the treatment of dermatomyositis and polymyositis in adults
National
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Local
2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups
Local
British Society for Rheumatology guideline on management of adults with idiopathic inflammatory myopathy syndrome including polymyositis and dermatomyositis
Local
International Guideline for Idiopathic Inflammatory Myopathy: Consensus Recommendations on Screening for Cancer in Patients with Myositis
Local